Shares of Dendreon (DNDN +16.1%) soared today after reporting a less-than-expected $0.33 a share net loss for the quarter. Revenues climbed 21.3% Y/Y to $78M on strength in its urology and oncology units, but the numbers still slightly missed analysts estimates by $2.7M.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.